Obalon Announces Upcoming Conference Presentations
November 06, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2018 Financial Results
November 02, 2018 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time
October 23, 2018 09:04 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
September 26, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018
August 29, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics Announces Closing of $10 Million Private Placement
August 27, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
August 07, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Promotes Kelly Huang, Ph.D. to President
August 02, 2018 07:55 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the promotion of Kelly Huang to the position of President, effective August 2, 2018. “Kelly...
Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time
July 24, 2018 10:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 24, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
June 06, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only...